Crexont ER 52.5 MG-210 MG cap 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F6T2G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,380
Award facts
- Contract value 100% obligated
- $3,379.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,379.61 to AmerisourceBergen Drug Corp for CREXONT ER 52.5 MG-210 MG capsules (120-count). This non-set-aside, competitively awarded contract features firm fixed-price terms with an ultimate completion date of November 26, 2025. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a prime vendor under the DLA Troop Support Medical program, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with pharmaceutical products distributed globally. This specific delivery order for CREXONT, a chronic pain and neurological medication, exemplifies the company's role in fulfilling ongoing federal medical supply requirements through flexible, competitively awarded contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26F6T2G?
SPE2DR26F6T2G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F6T2G worth?
The government has obligated $3,380 on SPE2DR26F6T2G.
Is contract SPE2DR26F6T2G an order under another contract?
Yes. SPE2DR26F6T2G is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6T2G competed?
The extent of competition for SPE2DR26F6T2G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award